FDANonrulemakingFDA-2021-N-0951
Who commented on this docket
Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments
9 organizations filed 9 public comments on Reconsidering Mandatory Opioid Prescriber Education Through a Risk Evaluation and Mitigation Strategy (REMS) in an Evolving Opioid Crisis; Public Workshop; Request for Comments, at the Food and Drug Administration. The comment window closed 1698d ago.
Organizations
9
Comments
9
RIN
—
Comment window
closed 1698d ago
Abstract
OPEN
Commenters (9)
- American Association of Nurse Anesthesiologytrade assoc.1 filing · confidence 85%
- American Massage Therapy Associationtrade assoc.1 filing · confidence 85%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- American Society of Addiction Medicinetrade assoc.1 filing · confidence 85%
- American Society of Anesthesiologiststrade assoc.1 filing · confidence 85%
- Boston University School of Medicineunverified attribution1 filing · confidence 70%
- CME Coalitiontrade assoc.1 filing · confidence 85%
- National Association of Chain Drug Storestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.